Julius Knowles's most recent trade in Keros Therapeutics Inc was a trade of 2,625 Common Stock done at an average price of $10.7 . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 04 Jun 2026 | 2,625 | 10,958 | - | 10.7 | 28,166 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | 03 Jun 2026 | 7,433 | 7,433 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 7,142 | 13,583 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale or transfer of securities back to the company at price $ 17.75 per share. | 21 Nov 2025 | 191,527 | 150,047 | - | 17.7 | 3,399,604 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale or transfer of securities back to the company at price $ 17.75 per share. | 21 Nov 2025 | 130,494 | 102,233 | - | 17.8 | 2,316,269 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | 04 Jun 2025 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,250 | 6,441 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | 01 Jun 2022 | 8,293 | 8,293 | - | - | Stock Options (right to buy) | ||
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.96 per share. | 03 Jan 2022 | 5,236 | 356,408 | - | 59.0 | 308,715 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.83 per share. | 03 Jan 2022 | 5,094 | 361,644 | - | 57.8 | 294,586 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.99 per share. | 03 Jan 2022 | 4,151 | 347,383 | - | 58.0 | 240,716 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.82 per share. | 03 Jan 2022 | 3,678 | 366,738 | - | 56.8 | 208,984 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.96 per share. | 03 Jan 2022 | 3,412 | 242,400 | - | 59.0 | 201,172 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.86 per share. | 03 Jan 2022 | 3,367 | 344,016 | - | 58.9 | 198,182 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.83 per share. | 03 Jan 2022 | 3,318 | 245,812 | - | 57.8 | 191,880 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.99 per share. | 03 Jan 2022 | 2,704 | 236,514 | - | 58.0 | 156,805 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.82 per share. | 03 Jan 2022 | 2,406 | 249,130 | - | 56.8 | 136,709 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.86 per share. | 03 Jan 2022 | 2,195 | 234,319 | - | 58.9 | 129,198 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.10 per share. | 03 Jan 2022 | 2,124 | 353,241 | - | 56.1 | 119,156 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.95 per share. | 03 Jan 2022 | 1,707 | 351,534 | - | 57.0 | 97,214 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.10 per share. | 03 Jan 2022 | 1,383 | 240,331 | - | 56.1 | 77,586 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.20 per share. | 03 Jan 2022 | 1,356 | 342,241 | - | 58.2 | 78,919 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.95 per share. | 03 Jan 2022 | 1,113 | 239,218 | - | 56.9 | 63,385 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 58.20 per share. | 03 Jan 2022 | 886 | 233,162 | - | 58.2 | 51,565 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.95 per share. | 03 Jan 2022 | 794 | 355,365 | - | 54.9 | 43,630 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 Jan 2022 | 667 | 341,574 | - | 59 | 39,353 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.95 per share. | 03 Jan 2022 | 524 | 241,714 | - | 55.0 | 28,794 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 03 Jan 2022 | 435 | 232,727 | - | 59 | 25,665 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.23 per share. | 03 Jan 2022 | 419 | 343,597 | - | 57.2 | 23,979 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 57.23 per share. | 03 Jan 2022 | 271 | 234,048 | - | 57.2 | 15,509 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.40 per share. | 03 Jan 2022 | 249 | 356,159 | - | 59.4 | 14,791 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 59.40 per share. | 03 Jan 2022 | 162 | 242,238 | - | 59.4 | 9,623 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.86 per share. | 01 Dec 2021 | 8,747 | 370,554 | - | 53.9 | 471,113 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.17 per share. | 01 Dec 2021 | 6,372 | 379,301 | - | 53.2 | 338,799 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.86 per share. | 01 Dec 2021 | 5,705 | 251,626 | - | 53.9 | 307,271 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 5,168 | 389,846 | - | 54.7 | 282,535 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.48 per share. | 01 Dec 2021 | 4,243 | 395,014 | - | 53.5 | 226,916 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.17 per share. | 01 Dec 2021 | 4,155 | 257,331 | - | 53.2 | 220,921 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 3,372 | 264,208 | - | 54.7 | 184,347 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 53.48 per share. | 01 Dec 2021 | 2,766 | 267,580 | - | 53.5 | 147,926 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 55.71 per share. | 01 Dec 2021 | 2,528 | 387,318 | - | 55.7 | 140,835 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 55.71 per share. | 01 Dec 2021 | 1,649 | 262,559 | - | 55.7 | 91,866 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.27 per share. | 01 Dec 2021 | 1,566 | 385,752 | - | 56.3 | 88,119 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 56.27 per share. | 01 Dec 2021 | 1,021 | 261,538 | - | 56.3 | 57,452 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 138 | 370,416 | - | 54.7 | 7,544 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 54.67 per share. | 01 Dec 2021 | 90 | 251,536 | - | 54.7 | 4,920 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 51.99 per share. | 01 Dec 2021 | 79 | 385,673 | - | 52.0 | 4,107 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 52.00 per share. | 01 Dec 2021 | 52 | 261,486 | - | 52 | 2,704 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.43 per share. | 01 Nov 2021 | 7,350 | 413,691 | - | 42.4 | 311,861 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.85 per share. | 01 Nov 2021 | 7,057 | 421,041 | - | 41.8 | 295,335 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 01 Nov 2021 | 6,067 | 402,854 | - | 41.7 | 252,691 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.43 per share. | 01 Nov 2021 | 4,797 | 279,760 | - | 42.4 | 203,537 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.85 per share. | 01 Nov 2021 | 4,599 | 284,557 | - | 41.8 | 192,468 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 41.65 per share. | 01 Nov 2021 | 3,957 | 272,692 | - | 41.6 | 164,809 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 01 Nov 2021 | 3,597 | 399,257 | - | 42.5 | 152,693 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 01 Nov 2021 | 3,252 | 410,439 | - | 42.1 | 136,909 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 01 Nov 2021 | 2,346 | 270,346 | - | 42.5 | 99,588 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 01 Nov 2021 | 2,120 | 277,640 | - | 42.1 | 89,252 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 43.04 per share. | 01 Nov 2021 | 1,518 | 408,921 | - | 43.0 | 65,335 | Common Stock |
| Keros Therapeutics Inc | Mr. Julius Knowles | Director | Sale of securities on an exchange or to another person at price $ 43.04 per share. | 01 Nov 2021 | 991 | 276,649 | - | 43.0 | 42,653 | Common Stock |